Please login to the form below

Not currently logged in
Email:
Password:

dosing

This page shows the latest dosing news and features for those working in and with pharma, biotech and healthcare.

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Allergan and partner Molecular Partners say a pair of two studies of abicipar show that the drug is non-inferior to monthly dosing with Roche and Novartis’blockbuster Lucentis (ranibizumab) when ... physicians, Regeneron has also been developing a

Latest news

More from news
Approximately 2 fully matching, plus 414 partially matching documents found.

Latest Intelligence

  • How can pharma build bridges with HCPs online? How can pharma build bridges with HCPs online?

    The programme enabled users to click through to a landing page with content specific to the product’s indications and dosing regimens, plus external links to NICE guidance, clinical data and

  • How Augmented reality is disrupting healthcare How Augmented reality is disrupting healthcare

    Differentiation with AR could highlight better efficacy, address new uses or dosing, or build awareness by leveraging an emotional aspect of the product.

  • Communication is the key to the participatory medicine model Communication is the key to the participatory medicine model

    If patients are more engaged in their treatment decisions, then they can consider what matters to them in approaching treatment - whether that be administration method, dosing frequency or the likelihood of

  • The good, the bad and the ugly The good, the bad and the ugly

    Small factors like position to market, route of administration and dosing frequency will play a large role in deciding market share.”.

  • Gene therapy Gene therapy

    However, the pathogenic origins of viral vectors and associated immune response mounted against them is their biggest limiting factor as it precludes regular or even repeat dosing.

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics